Casper Binding

[Casper Binding @BindingCasper]

Proud to present findings from the Danish registers in the EHJ-CVP. Treatment with Apixaban was associated with lower risk of bleeding compared to treatment with VKA among patients with reduced kidney function.
https://t.co/ZewqUHgjcH

[European Society of Cardiology Journals @ESC_Journals]

Efficacy and safety of #DOACs according to #renal function in #AF populations: data from >26K patients from Danish nationwide registers 🇩🇰 https://t.co/8mAaUI3etG @BindingCasper @bonde_nissen @uni_copenhagen @doreen_sy @MattiaGalli10 @FeliceGragnano #AFib #CKD #EHJPharmacotherapy

[European Society of Cardiology Journals @ESC_Journals]

Efficacy and safety of #DOACs according to #renal function in #AF populations: data from >26K patients from Danish nationwide registers 🇩🇰 https://t.co/8mAaUI3etG @BindingCasper @bonde_nissen @uni_copenhagen @doreen_sy @MattiaGalli10 @FeliceGragnano #AFib #CKD #EHJPharmacotherapy

[JACC Journals @JACCJournals]

Can DOACs help decrease the instance of osteoporotic fractures in patients with #AFib? See the latest research in #JACC. https://t.co/LVkWswVTfS @BindingCasper @uni_copenhagen

[Casper Binding @BindingCasper]

Proud to present our findings @CopCard in the latest edition of @JACCJournals. DOAC treatment was associated with lower risk of osteoporotic fractures compared to VKA treatment.

[JACC Journals @JACCJournals]

DOAC-treated #AFib patients have a lower risk of osteoporotic fractures than those treated with VKAs. Dr. @BindingCasper and colleagues from @uni_copenhagen present their research in #JACC. https://t.co/5mFOGBglNk

[Copenhagen Cardiovascular Research Center @CopCard]

In this @JACCJournals study by @BindingCasper @bonde_nissen et al @CopCard the 2y risk of fracture 🦴 was small in #AFib ptt 💗and only 0.7% higher ⬆️ with #VKA vs #DOAC (3.1% vs 3.8%). https://t.co/HRsRxyrAAI

#cardiotwitter #Cardiology #noac